Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ozone (O3) is a highly reactive gas used in medical therapy for its potent anti-inflammatory, analgesic, and antioxidant properties. In the clinical trial conducted by Tanta University for carpal tunnel syndrome (CTS), medical ozone is administered via a single local injection into the carpal tunnel, often in combination with lidocaine to mitigate procedural pain. The therapeutic effect of ozone in CTS is attributed to its ability to reduce perineural edema, inhibit the release of pro-inflammatory cytokines (such as TNF-α and IL-1), and improve oxygen delivery to the ischemic median nerve. This treatment aims to provide long-term symptomatic relief and improve functional outcomes in patients with mild-to-moderate CTS.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ozone + lidocaine.